Tag: CBD-
Cannabis Does Not Impact Nonmedical Opioid Use in Opioid Use Disorder
No association seen between cannabis use and nonmedical opioid use in those receiving pharmacotherapies for OUD
FDA Says Marijuana Should Be Reclassified as Less Risky Drug
Currently, cannabis is classified as a Schedule I controlled substance, a category that includes heroin and LSD
Medical Cannabis Use for Chronic Pain Linked to New-Onset Arrhythmia
Increased risk for new-onset arrhythmia observed; most pronounced during the first 180 days
One in Eight Older Adults Reports Using Cannabis in Past Year
Use more likely among unmarried or unpartnered adults and those consuming alcohol
Maternal Cannabis Use Linked to Adverse Pregnancy Outcomes
Ongoing cannabis use during pregnancy linked to pregnancy outcomes known to be related to placental dysfunction
In Utero Exposure to Cannabis Tied to Worse Neonatal Outcomes
Impact seen on birth weight, preterm birth, neonatal intensive care unit admission
Cannabis Use Disorder Increasing Among Vets With Psychiatric Disorders
Authors call for increased monitoring of cannabis use, particularly in people with bipolar and psychotic-spectrum disorders
Georgia to Be First State to Let Pharmacies Sell Low-Dose Cannabis
Meanwhile, the sale of marijuana is still illegal on a federal level
Cannabis Use Disorder Tied to Incident Cardiovascular Disease Events
Higher risk for incident events seen over seven years of follow-up
Prescribed Medical Cannabis Use Tied to Better Health-Related Quality of Life
Findings seen in real-world patients with a range of chronic health conditions
